Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.

Guest:

William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute. He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He is affiliated as research fellow and managing director with the Center for the Study of Statesmanship at The Catholic University of America (CUA), where he earned his PhD.

Related research: Analysis: ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments

Get new episodes of Hubwonk in your inbox!

Related Posts:

Ascending Justice: Where Judge Ketanji Brown Jackson Will Fit in New Court

Hubwonk host Joe Selvaggi talks with constitutional scholar Ilya Shapiro about Judge Ketanji Brown Jackson’s nomination hearings and what her background and responses reveal about her views on the Constitution, the role of the Supreme Court, and her likely judicial positions relative to her fellow justices.

Exploiting Charity Drugs: Hospital Program Earns Billions But Forgets Mission

Hubwonk host Joe Selvaggi talks with Pioneer Institute’s Dr. Bill Smith about his recently released paper entitled, "340B Drug Discounts, An Increasingly Dysfunctional Federal Program," which analyzes the evolution of a well-intentioned program to offer discounted drugs to the uninsured from a benefit that had helped charitable hospitals to one that has exploded to generate billions in profits while serving fewer uninsured.

Rent Control Redux: Mayor’s Committee Likely to Provide Astroturf Over Expertise

Hubwonk host Joe Selvaggi talks with Doug Quatrocchi, executive director of Masslandlords.net about the historical effects of rent control in Boston and Cambridge in the past and discuss the gap between the stated goals and the likely outcome of Boston Mayor Wu’s 25 member Rent Stabilization Advisory Committee.

Massachusetts Hospitals Pull Back on Charity Care as Revenue from Federal 340B Drug Discount Program Explodes

Over the past decade, the revenue for hospitals generated by the federal 340B drug discount program, initially intended to serve low-income, uninsured populations, has exploded even while a number of important Massachusetts hospitals have reduced the level of charity care they provide, according to a new study published by Pioneer Institute. The Pioneer Institute study, “340B Drug Discounts: An Increasingly Dysfunctional Program,” notes that nationwide, 340B drug sales rose from $9 billion in 2014 to $38 billion in 2020.

Ich Bin Ukrainer: European Nation Existential Fight Against Aggression

Hubwonk host Joe Selvaggi talks with former CEO of Kyiv Post and senior fellow at the Institute for the Study of War Nataliya Bugayova about her research on the rise of Vladimir Putin and how it can inform understanding of the Russian invasion, particularly when viewed through the eyes of Ukrainians.

Successful Aging Support: Reimagining Effective and Affordable Long-Term Care Solutions

Hubwonk host Joe Selvaggi talks with Brookings Institution Senior Fellow and healthcare policy expert Stuart Butler about the challenge of building long-term care systems and institutions that will support Americans as they age, without depleting assets and bankrupting the social safety net. 

Pandemic Dead Reckoning: Unseen Casualties of Public Health Interventions

Hubwonk host Host Joe Selvaggi talks with Pioneer Institute’s Senior Fellow Dr. Bill Smith about new evidence that during the past two years of the pandemic, there were as many unseen excess deaths from non-Covid-related diseases as seen from Covid. They discuss the need for public health leaders to pivot their messaging to address this hidden mortality.

Olympic-Scale Doctor Shortage: Tapping International Talent

Host Joe Selvaggi talks with Pioneer Institute's Senior Healthcare Policy Fellow Josh Archambault about the shortage of doctors in the U.S. and the potential for licensing reform to attract medical expertise from around the world to reduce future healthcare shortages and provide incentives for immigrating professionals to work in underserved communities.

Transit Innovation Explored: A Bus As Fast As A Train?

Hubwonk host Joe Selvaggi talks with transportation expert Ian Ollis about the findings of his new research paper, "Bus Rapid Transit: Costs and Benefits of a Transit Alternative," which examines the benefits of building Bus Rapid Transit to serve communities looking for faster transit alternatives to a car.

Who Counts Electors: Tackling Ambiguities In Federal Election Laws

Hubwonk host Joe Selvaggi talks with constitutional scholar Thomas Berry about the process for electing U.S. presidents and the efforts underway to modernize the Electoral Count Act of 1887 to forestall frivolous challenges in the future.